Posted on Wed, Jun 16, 2010
Rory O’Driscoll is a successful VC by anyone’s standards. He’s been in the business for almost two decades and invests in mobile, internet, and enterprise software companies. Some of his successful deals include: Omniture (Nasdaq, acquired by Adobe for $1.8B), Connect, NetGenesis and acquisitions including ScanSafe (acquired by Cisco), Frontbridge (acquired by Microsoft), Zone Labs (acquired by Checkpoint), Placeware, (acquired by Microsoft), and OuterBay (acquired by HP).
If you want to get to know him better, this podcast provides a rare insight into his personality and perspective.
Rory O’Driscoll: His Background and Advice to Entrepreneurs Seeking Funding [7:49m]
Posted on Wed, Apr 21, 2010
Jeff Calcagno's impressive background as both a clinician and executive in the healthcare industry has provided the necessary background for his role as an investor. In this podcast, Jeff describes how he came to ScaleVP and where he believes the upside is for smart investing today.
Jeff Calcagno Healthcare Investment Investor Looks Ahead at the Opportunities for the Industry [5:07m]
Posted on Fri, Mar 26, 2010
The last 12 months have been good for Scale Venture Partner’s Managing Director Mark Brooks. As an investor in healthcare services, and medical devices, Mark delves into his successes, and speaks to his current investments and their bright future.
Posted on Fri, Oct 30, 2009
Managing Director, Rob Theis, who invests in technology infrastructure and applications tells how it is a great time to invest in successful consumer applications that can be brought to the enterprise.
His latest investment, HubSpot is an example of such an investment. HubSpot has incorporated the products, processes and methodologies to make best of breed marketing applications for small and medium sized businesses.
Posted on Tue, Oct 27, 2009
Andy Vitus discusses how he approaches investing in cloud computing. He describes how ScaleVP talked to hundreds of directors in data centers so they could learn how to work more efficiently. As an investor in start ups, Andy shares ScaleVP’s most cost-effective methods for growing a company today.
Posted on Sun, Sep 27, 2009
It’s August 2009 and in the last 12 months, Lou Bock’s portfolio has had some impressive success. He talks about how Zogenix, Horizon Therapeutics, Somaxon, Prestwick Pharmaceuticals and Orexigen have all done well. The Scale Venture Partners Managing Director has seen two positive Phase III outcomes, 2 FDA approvals and one progressing to approval since August 2008.
Posted on Tue, Sep 15, 2009
Managing Director of Scale Venture Partners, Mark Brooks tells listeners what types of deals he likes most. He also describes his analytical investment process and what tips he has for entrepreneurs who believe they have an investment for ScaleVP.
Posted on Sun, Jun 21, 2009
Managing Director of Scale Venture Partners, Sharon Wienbar gives listeners her perspective on life of a venture capitalist and her investment interests. She is most excited about crowd sourcing, vertical content and business software-as-a-service. Despite the current recessionary environment, Sharon’s outlook remains upbeat.
Posted on Sat, Jun 20, 2009
Reflecting on his life in venture capital, Scale Venture Partners Managing Director, Jim Jones shares his thoughts on the best areas for investment today. Jim sees three key trends as most intriguing: the cost of data in the enterprise, energy efficiency, and the destruction of the personal computer. He speaks out candidly on these trends and what is most challenging about this environment.
Posted on Fri, Jun 19, 2009
Investing in healthcare venture capital today is not without challenges. Lou Bock, Scale Venture Partner’s Managing Director believes capital efficiency and regulatory hurdles are most emphatically affecting healthcare investors. Lou shares these insights and others and discusses what is most important to him in an investment.